Authentication of Oviductus Ranae and its original animals using molecular marker by Yang, X. G. et al.
Oviductus Ranae, a valuable Chinese crude drug, is
recorded in Pharmacopoeia of the People’s Republic of China
(2000 edition) as a dried oviduct of the female Chinese
brown frog, Rana chensinensis, distributing mainly in north-
eastern China. In the application of Chinese medicine,
Oviductus Ranae is used to replenish the kidney essence, to
nourish the yin, and to moisten the lung.1) Unfortunately,
substitutes or adulterants of Oviductus Ranae are found on
the Chinese medicinal market, and the most common ones
are made of oviducts of Bufo gargarizans gargarizans, Pelo-
phylax nigromaculata, or P. plancyi plancyi.2) Swelling ca-
pacity is the criterion recommended in the Chinese Pharma-
copoeia to identify the genuine product. But it varies greatly
with water temperature, soaking duration, and even among
individuals, and thus is unsatisfactory in most cases.3) It is
also very difficult to distinguish the actual product from its
substitutes/adulterants by morphological or chemical charac-
teristics.3) In our previous report, we designed a pair of allele
specific primers to identify the genuine product of Oviductus
Ranae based on DNA sequence of 12S rRNA gene.4) How-
ever, this gene is relatively conservative with less variation
among species of frogs. Although we can discriminate three
brown frogs: R. chensinensis, R. amurensis and R. huanre-
nensis from other frogs and toads by allele specific poly-
merase chain reaction (PCR) using this primer pair, we are
still unable to distinguish R. chensinensis from the other two
kinds of brown frogs. The purpose of the present study was
to design more sensitive primer pairs based on mitochondrial
Cyt b sequences to identify each of the three brown frogs.
MATERIALS AND METHODS
Samples Samples of Oviductus Ranae were purchased
respectively from 5 drugstores in China: Sichuan Derentang
Traditional Chinese Medicinal Materials Co. (Sichuan),
Dalian Traditional Chinese Medicinal Materials Co.
(Dalian), Beijing Tongrentang Traditional Chinese Medicinal
Materials Co. (Beijing), Jiangsu Traditional Chinese Medici-
nal Materials Co. (Jiangsu) and Nanjing Cunxintai Tradi-
tional Chinese Medicinal Materials Shop (Nanjing). Produc-
ing area of these samples was all labeled as northeastern
China by the vendors. We selected 10 samples randomly
from each purchasing panel and 3 oviduct samples taken
from the original animals of R. huanrenensis for DNA ex-
traction and PCR identification.
For DNA sequencing and testing primers designed for au-
thentication of the drugs, a total of 9 species of the original
animal including 24 individuals covering all reported substi-
tute species were sampled and their taxonomic assignment
follows Fei5) (Table 1).
DNA Extraction and Amplification The procedure of
DNA extraction from both crude drugs and original animals
was the same as that described in a previous report.4)
Based on the analysis of DNA sequence data of human,6)
Xenopus laevis7) and some Ranid frogs,8—11) a pair of univer-
sal primers L14847 (59-ACATCTCAGCATGATGAAACTT-
CGG-39) and H15230 (59-TACTGAGAAGCCCCCTCAAA-
TTCATTG-39) was designed for amplifying Cyt b gene frag-
ment from all frogs mentioned above in the present study. A
total of 30 m l of PCR reaction mixture was composed of
103buffer 3 m l, 25 mmol/l Mg21 2 m l, 2 mmol/l dNTPs 2 m l,
10 pmol/ m l of each universal primer 1 m l, 1 unit of Taq DNA
polymerase (Promega), 10 mg/ml BSA 0.2 m l, and template
DNA 10—100 ng. Amplification was carried out in a Ge-
neAmp PCR System 2400 (Perkin Elmer) or PTC-200 ther-
mocycler (MJ Research). Samples were denatured at 95 °C
for 5 min and subjected to 30 cycles of 40 s at 95 °C, 40 s at
52 °C, 90 s at 72 °C, and a final extension of 7 min at 72 °C.
Sequencing of PCR Product PCR products were puri-
fied using a DNA purification kit (Shanghai Watson Bioengi-
neering Inc.) according to the manufacturer’s instruction, and
then sequenced with BigDyeTM on an ABI PRISMTM 310
Genetic Analyzer (Perkin Elmer). Nonspecific amplicons ex-
isting in some reactions usually generated a strong back-
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Two pairs of diagnostic primers, IHm01-L/IHm01-H and IHm02-L/IHm02-H, for distinguishing the Chi-
nese crude drug Oviductus Ranae from its substitutes were designed based on sequences of Cyt b gene fragment
of the original animals of the drug and substitutes. Total DNAs were extracted from crude drugs purchased from
five drugstores in different regions, as well as from original animals of the drug, Rana chensinensis, and seven
species of related ranid species. Diagnostic polymerase chain reactions (PCRs) were performed using the two
pairs of primers with the total DNAs of the original animals as a template. The result showed that a 240 bp DNA
segment was clearly amplified from all templates of Rana chensinensis using primers IHm01-L and IHm01-H,
whereas no DNA band appeared from other templates. While using primers IHm02-L and IHm02-H, we got a
clear 140 bp DNA band from all the templates of R. huanrenensis and 3 oviducts of the same species, no PCR
product was observed from the other samples. A set of PCR reactions was employed to identify crude drugs from
the five drugstores using the two pairs of primers together with HsmL1 and HsmH1 reported in our previous
study. The results show that only 20% of the Oviductus Ranae currently sold in markets are qualified products
and the rest are not.
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ground during DNA sequencing. To solve this problem, a
strategy of TA cloning sequencing was employed in our 
experiments. The vector PMD18-T was purchased from
TaKaRa Co. Recombined plasmid was extracted with a QI-
Aprep spin miniprep kit (QIAGEN) and sequenced as de-
scribed above.
Diagnostic PCR Based on DNA sequence data of Cyt b
gene fragment obtained in the present research and cited
from published papers, we designed two pairs of allele spe-
cific primers, IHm01-L (59-TTTCATCTATCGCCCATATCT-
GCCGG-39) and IHm01-H (59-CAGAAGGATATTTGGC-
CTCATGGTAAC-39), IHm02-L (59-ACTTCTCTGGCATT-
CTCATCTATCGCA-39) and IHm02-H (59-CCATAATAAA-
GACCTCGCCCAATATGA-39), for the identification of
Oviductus Ranae. The first pair was specialized to identify R.
chensinensis, and could be used to specifically amplify a
240 bp DNA segment from a template of this species only.
The second pair was specialized to label R. huanrenensis,
and a 140 bp DNA band would be generated only from R.
huanrenensis DNA in the amplification. Diagnostic PCRs
were performed under several annealing temperatures to esti-
mate a suitable range of temperature variation. Positive con-
trols were also performed for the same set of templates using
universal primers L14847 and H15230 annealing at 52 °C.
PCR products were tested by electrophoresis in 1.5% agarose
gel stained with ethidium bromide.
RESULTS
About 360 bp Cyt b gene fragment was amplified from 
16 samples, R. chensisnensis (5 individuals), R. amurensis (3 
individuals), R. huanrenensis (3 individuals), R. zhenhaien-
sis, R. chaochiaoensis, R. omeimontis, Pelophylax nigromac-
ulata, and P. p. plancyi, and then sequenced directly or via
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Table 1. Samples of Original Animal Used in Present Study
Speciesa) Code Number Source
Rana chensinensis (M) Rchem 3 Mudanjiang, Heilongjiang
Rana chensinensis (S) Rches 5 Shenyang, Liaoning
Rana chensinensis (Y) Rchey 1 Yuzhong, Gansu
R. amurensis Ramum 5 Mudanjiang, Heilongjiang
R. huanrenensis Rhuah 3 Huanren, Liaoning
R. zhenhaiensis Rzhez 1 Zhenhai, Zhejiang
R. chaochiaoensis Rcham 1 Muli, Sichuan
R. omeimontis Romee 1 Emei, Sichuan
Pelophylax nigromaculata Pnigh 1 Huoqiu, Anhui
P. p. plancyi Pplaw 1 Wuhu, Anhui
Bufo g. gargarizans Bufo 2 Nanjing, Jiangsu
a) The species of original animals are named following ref. 5.
Fig. 1. Agarose Gel Electrophoresis of PCR Identification of Original Animals
A: Positive control with universal primers. B: Allele specific PCR with IHm01-L and IHm01-H. C: Allele specific PCR with IHm02-L and IHm02-H. 1—9: Rana chensinensis,
10—14: R. amurensis, 15—17: R. huanrenensis, 18—20: 3 oviducts of R. huanrenensis, 21: R. zhenhaiensis, 22: R. omeimontis, 23: R. chaochiaoensis, 24: Pelophylax nigromacu-
lata, 25: P. p. plancyi, 26—27: Bufo g. gargarizans, M: DNA marker, DL2000 (TaKaRa), N: negative control without DNA template.
cloning. The sequences have been submitted to GenBank
with accession numbers of AF274914—AF274924 and
AF274926—274930. Corresponding Cyt b sequence data of
Bufo g. gargarizans was cited from GenBank (accession
number AF171195). After alignment of these sequences, ge-
netic distance was estimated as 0.3—6.4% among 5 samples
of R. chensinensis, 11.4—19.3% between R. chensinensis
and the other two species of brown frogs from northeastern
China, 16.7—19.0% between R. chensinensis and Pelophylax
nigromaculata or P. p. plancyi, and 58.6—61.6% between R.
chensinensis and Bufo g. gargarizans (Table 3).
Before diagnostic PCR for authentication of crude drugs,
we employed the universal primer pair and the two allele spe-
cific primer pairs to amplify DNA templates of the 27 origi-
nal animals (including 3 oviducts of R. huanrenensis) to ver-
ify the primers. The result of amplification showed that a
240 bp DNA segment was clearly amplified from 9 templates
of R. chensinensis annealing at 60 °C using primers IHm01-L
and IHm01-H, whereas no DNA band appeared in amplifica-
tion with other templates under the same reaction conditions.
When annealing temperature rose to 70 °C, the DNA seg-
ment was still amplified well from R. chensinensis templates.
While using primers IHm02-L and IHm02-H with an anneal-
ing temperature at 55 °C, we got a clear 140 bp DNA band
from each reaction containing a template from R. huanrenen-
sis and 3 oviducts of the same species, but no PCR product
was observed in the amplifications of the other samples. The
results were repeated well. Positive controls for all DNA tem-
plates produced a DNA fragment about 400 bp in size, indi-
cating that all templates are qualified for PCR (Fig. 1).
In the process of crude drug identification, about a 400 bp
DNA fragment was amplified from all 50 templates ran-
domly sampled from 5 purchasing panels using universal
primers with annealing at 52 °C, indicating the DNA from
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Fig. 2. Agarose Gel Electrophoresis of PCR Identification of Crude Drugs
The lower cases at the bottom of each picture indicate samples originated from different regions. a: Sichuan Denrentang Tradition Chinese Medicinal Material Co., b: Dalian
Tradition Chinese Medicinal Material Co., c: Beijing Tongrentang Tradition Chinese Medicinal Material Co., d: Jiangsu Tradition Chinese Medicinal Material Co., e: Nanjing
Cunxintai Tradition Chinese Medicinal Material Shop, 1~10: number of samples, M: DNA marker, DL2000 (TaKaRa), N: negative control without DNA template. The capital let-
ters at the bottom of pictures indicate PCRs performed with different primer pairs. A: Positive control with universal primers. B: Allele specific PCR with IHm01-L and IHm01-H.
C: Allele specific PCR with IHm02-L and IHm02-H.
these crude drugs were good enough for PCR (Fig. 2, Table
2). Diagnostic PCR for these samples with primers
HsmL1/HsmH1 marked on 12S rRNA gene showed positive
results in most cases, and these positive amplifications im-
plied the templates originated from one of the three brown
frogs mentioned above.4)
For more accurate identification, further allele specific
PCRs were carried out using IHm01-L and IHm01-H anneal-
ing at 60 °C, IHm02-L and IHm02-H annealing at 55 °C. In
the former reaction, a 240 bp DNA fragment was amplified
only from 10 Sichuan samples, which indicated the original
animal of these crude drugs was R. chensinensis. In the latter,
a 140 bp DNA fragment was amplified from 10 Dalian sam-
ples and 2 Beijing samples (Fig. 2, Table 2). The results sug-
gested these crude drugs were originated from R. huanrenen-
sis.
DISCUSSION
For the authentication of Oviductus Ranae, allele specific
primers HsmL1/HsmH1 located on 12S rRNA gene could be
used to distinguish the crude drugs made of R. chensinensis,
R. amurensis and R. huanrenensis from those made of other
ranid species. But the primer pair was unable to separate the
crude drugs made of the three brown frogs.4) Cyt b gene with
a higher variation rate has been proved a good molecular
marker for close affinitive species in the authentication of
some animal crude drugs.12,13) For more perfect identifica-
tion, the gene of Cyt b was selected as a DNA molecular
marker to single out each brown frog species. After aligning
and comparing a total of 24 sequences of this gene, including
8 sequences obtained from published data, we designed two
pairs of specified primers for identification of R. chensinensis
and R. huanrenensis, respectively. Because of the limitation
of available data, no proper position on the current segment
was found for designing primers that would be specialized
only for R. amurensis. However, if we use these two pairs of
primers together with HsmL1/HsmH1 reported in our previ-
ous study to perform a set of PCR reactions, the name of the
above species could be figured out easily (Table 2).
Ten samples were randomly selected from each purchasing
panel for PCR identification using the above allele specific
primers. The results showed that the 10 samples from
Sichuan originated from R. chensinensis, and the 10 samples
from Dalian and 2 samples from Beijing originated from R.
huanrenensis. Those from Jiangsu and Nanjing as well as 8
samples from Beijing were rejected by both IHm01-
L/IHm01-H and IHm02-L/IHm02-H amplification. In these
rejected samples, 10 from Jiangsu and 2 from Nanjing were
accepted by HsmL1/HsmH1 amplification. Therefore, we
presumed that they originated from R. amurensis, and from
them we randomly selected two samples for further sequence
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Table 2. PCR Identification Results of 10 Samples from Each Purchasing Panel Using Diagnostic Primers
Primer pairs
Purchasing panel
L14847/H15230 HsmL1/HsmH1 IHm01-L/IHm01-H IHm02-L/IHm02-H
Sichuan 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 2 2 2 2 2 2 2 2 2 2
Dalian 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 2 2 2 2 2 2 2 2 2 2 1 1 1 1 1 1 1 1 1 1
Jiangsu 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2
Beijing 1 1 1 1 1 1 1 1 1 1 2 2 2 1 2 2 1 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 1 2 2 1 2 2 2
Nanjing 1 1 1 1 1 1 1 1 1 1 1 2 2 2 2 2 2 2 2 1 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2
Note: “1” and “2” denote positive and negative amplifications, respectively. Positive amplifications using L14847/H15230 show all samples are qualified for PCR reaction.
Samples generating positive amplifications with primer IHm01–L/IHm01–H are R. chensinensis, and those generating positive amplifications with IHm02–L/IHm02–H are R.
huanrenensis. Samples generating positive amplifications with HsmL1/HsmH1 but negative amplifications with IHm01–L/IHm01–H or IHm02–L/IHm02–H are R. amurensis. The
species names of samples generating negative amplifications with all primer pairs except L14847/H15230 are uncertain but not brown frogs.
Table 3. Numbers of Transitions/Transversions (Upper Triangle) and the Percentage of Sequence Diversity (Lower Triangle) for Cyt b Gene of 9 Species
of Original Animal Examined with Gaps Deleted in Each Pairwise Comparison
Codea) 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
1 Rchem 1 0 0 1/5 17/3 36/10 37/7 39/9 52/15 52/15 52/16 42/17 40/12 43/18 38/25 39/25 101/118
2 Rchem 2 0.3 0 1/4 17/2 36/9 39/8 39/8 52/14 52/14 52/15 42/16 40/11 43/17 38/24 39/24 103/117
3 Rches 1 0.6 0.3 1/5 17/3 36/10 39/9 39/9 52/15 52/15 52/16 42/17 40/12 43/18 38/25 39/25 102/118
4 Rches 2 1.8 1.5 1.8 15/4 30/11 36/10 35/10 48/16 48/16 48/17 41/18 38/13 42/19 38/25 39/25 91/113
5 Rchey1 6.4 6.1 6.4 6.3 33/7 32/5 31/5 44/10 44/10 43/11 37/11 31/7 38/13 33/20 30/22 82/99
6 Ramum  1 13.8 13.5 13.8 11.4 12.8 3/4 2/4 48/11 48/11 48/12 39/14 31/10 44/12 41/21 39/23 95/109
7 Ramum 2 12.8 13.1 13.3 13.7 11.9 2.1 1/2 49/10 49/10 49/11 42/12 35/9 45/11 42/20 40/22 106/115
8 Ramum 3 13.3 13.1 13.3 13.4 11.5 1.8 0.8 49/10 49/10 49/11 42/10 36/9 47/9 44/18 42/20 109/113
9 Rhuah 1 18.6 18.3 18.6 19.0 17.3 17.7 16.4 16.4 1 0 41/18 44/13 26/13 35/22 34/24 104/117
10 Rhuah 2 18.6 18.3 18.6 19.0 17.3 17.7 16.4 16.4 0.3 1 41/18 44/13 26/13 34/22 33/24 106/117
11 Rhuah 3 18.9 18.6 18.9 19.3 17.3 18.0 16.7 16.7 0.3 0.6 41/19 43/14 26/14 48/20 52/15 104/118
12 Rzhez 1 16.4 16.1 16.4 17.6 15.4 15.9 15.0 14.4 16.4 16.4 16.7 33/7 33/9 36/24 37/26 110/113
13 Rcham 1 14.7 14.4 14.7 15.2 12.2 12.3 12.5 12.7 16.1 16.1 16.1 11.3 38/8 37/23 37/25 108/112
14 Romee 1 16.9 16.7 16.9 18.2 16.3 16.8 15.6 15.6 10.8 10.8 11.1 11.7 13.0 33/21 34/23 103/118
15 Pnigh 1 17.5 17.2 17.5 18.8 17.0 18.6 17.2 17.2 15.8 15.6 15.8 16.7 17.0 15.0 3/2 102/115
16 Pplaw 1 17.8 17.5 17.8 19.0 16.7 18.6 17.2 17.2 16.1 15.8 16.1 17.5 17.6 15.8 1.4 99/117
17 Bufo 61.5 61.6 61.6 60.1 58.6 61.6 61.9 62.2 61.9 62.5 62.2 62.5 62.3 61.9 60.8 60.5
a) See Table 1 for explanation of the code.
analysis. Only one or two varied sites were found when com-
paring the 240 bp DNA segment of Cyt b gene with that of R.
amurensis. Sequence variation rates among the three individ-
uals are 0.4 to 0.8%, which indicates they are conspecific.
The results in Table 2 also show that only 10 samples of
one purchasing panel originated from R. chensinensis, 12
samples were from R. huanrenensis, another 12 samples
were from R. amurensis and the rest from unknown ranid
frogs but not brown frogs. In other words, only twenty per-
centage of Oviductus Ranae purchased from the market are
genuine products. Traditionally, dried oviduct of R. huanre-
nensis or R. amurensis is also served as Oviductus Ranae by
local people in northeastern China. However, no research on
their pharmacological effect has been published and these
substitutes have not yet been authorized officially by Chinese
Pharmacopoeia.
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